2 completed, 1 terminated. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Recurrent Grade 3 Follicular Lymphoma: new trials by email Literature Review of Recurrent Grade 3 Follicular Lymphoma trials Research Report on Recurrent Grade 3 Follicular Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications internet-based intervention, questionnaire administration, psychosocial assessment and care - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 3 | Completed | Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium | 1337 | 2008-08-01 | 2012-03-07 |
| Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Cyclophosphamide and Rituximab, Filgrastim, Chemotherapy or Radiation therapy - Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma | Phase 2 / Phase 3 | Terminated | Medical College of Wisconsin | 30 | 2004-08-01 | 2023-01-05 |
| Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma aldesleukin, filgrastim, cyclophosphamide - Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma | Phase 3 | Completed | National Cancer Institute (NCI) | 206 | 1995-05-01 | 2013-02-28 |
Lymphoma, Follicular (3) · Burkitt Lymphoma (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Large-Cell, Immunoblastic (2) · Lymphoma, Non-Hodgkin (2) · Blast Crisis (1) · Congenital Abnormalities (1) · Depression (1) · Fatigue (1) · Hodgkin Disease (1) · Leukemia, Hairy Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · DNA Virus Infections (2) · Epstein-Barr Virus Infections (2) · Herpesviridae Infections (2) · Infections (2) · Lymphoma, B-Cell (2) · Tumor Virus Infections (2) · Virus Diseases (2)
Cyclophosphamide (2) · Etoposide (2) · Filgrastim (2) · Granulocyte Colony-Stimulating Factor (2) · Radiotherapy (2) · Carmustine (1) · Counseling (1) · Drug Therapy (1) · Interleukin-2 (1) · Methotrexate (1) · Peripheral Blood Stem Cell Transplantation (1) · Psychiatric Rehabilitation (1) · Radiation (1) · Rituximab (1) · Tacrolimus (1)
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1) · Medical College of Wisconsin (1) · National Cancer Institute (NCI) (1)
United States (3)
John Thompson (1) · Karen Syrjala (1) · Mary Horowitz, MD (1)
PMID 18256325, PMID 21073974, PMID 32628342, PMID 33420905, PMID 36282798
R01CA112631 (1), U01HL069294 (1), U10CA032102 (1), U24CA076518 (1)